16.73 USD
+0.03 (+0.18%)
Overall DHCNI gets a fundamental rating of 2 out of 10. We evaluated DHCNI against 128 industry peers in the Diversified REITs industry. DHCNI has a bad profitability rating. Also its financial health evaluation is rather negative. DHCNI is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
DHCNI had negative earnings in the past year.
In the past year DHCNI had a positive cash flow from operations.
DHCNI had negative earnings in 4 of the past 5 years.
In multiple years DHCNI reported negative operating cash flow during the last 5 years.
1.2 Ratios
DHCNI has a Return On Assets of -7.52%. This is amonst the worse of the industry: DHCNI underperforms 86.72% of its industry peers.
The Return On Equity of DHCNI (-20.85%) is worse than 83.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.52% | ||
| ROE | -20.85% | ||
| ROIC | N/A |
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of DHCNI (17.58%) is worse than 93.75% of its industry peers.
In the last couple of years the Gross Margin of DHCNI has declined.
The Profit Margin and Operating Margin are not available for DHCNI so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 17.58% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
2. Health
2.1 Basic Checks
DHCNI does not have a ROIC to compare to the WACC, probably because it is not profitable.
DHCNI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, DHCNI has more shares outstanding
The debt/assets ratio for DHCNI is higher compared to a year ago.
2.2 Solvency
DHCNI has an Altman-Z score of 0.28. This is a bad value and indicates that DHCNI is not financially healthy and even has some risk of bankruptcy.
DHCNI has a Altman-Z score of 0.28. This is in the lower half of the industry: DHCNI underperforms 64.06% of its industry peers.
DHCNI has a Debt/Equity ratio of 1.61. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.61, DHCNI is doing worse than 61.72% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.61 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.28 |
ROIC/WACCN/A
WACC6.57%
2.3 Liquidity
A Current Ratio of 6.66 indicates that DHCNI has no problem at all paying its short term obligations.
With an excellent Current ratio value of 6.66, DHCNI belongs to the best of the industry, outperforming 96.88% of the companies in the same industry.
DHCNI has a Quick Ratio of 6.66. This indicates that DHCNI is financially healthy and has no problem in meeting its short term obligations.
DHCNI has a better Quick ratio (6.66) than 96.88% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.66 | ||
| Quick Ratio | 6.66 |
3. Growth
3.1 Past
DHCNI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.32%.
Looking at the last year, DHCNI shows a small growth in Revenue. The Revenue has grown by 4.10% in the last year.
The Revenue has been growing slightly by 7.53% on average over the past years.
EPS 1Y (TTM)-22.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3500%
Revenue 1Y (TTM)4.1%
Revenue growth 3Y2.63%
Revenue growth 5Y7.53%
Sales Q2Q%4.03%
3.2 Future
Based on estimates for the next years, DHCNI will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.25% on average per year.
The Revenue is expected to grow by 3.37% on average over the next years.
EPS Next Y20.64%
EPS Next 2Y17.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.66%
Revenue Next 2Y3.37%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for DHCNI. In the last year negative earnings were reported.
Also next year DHCNI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
91.41% of the companies in the same industry are cheaper than DHCNI, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 27.51 |
4.3 Compensation for Growth
A more expensive valuation may be justified as DHCNI's earnings are expected to grow with 17.25% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.25%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a yearly dividend of 0.82%, DHCNI is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.34, DHCNI's dividend is way lower than its industry peers. On top of this 92.19% of the companies listed in the same industry pay a better dividend than DHCNI!
Compared to an average S&P500 Dividend Yield of 2.32, DHCNI's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.82% |
5.2 History
The dividend of DHCNI decreases each year by -45.60%.
DHCNI has been paying a dividend for over 5 years, so it has already some track record.
DHCNI has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-45.6%
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
The earnings of DHCNI are negative and hence is the payout ratio. DHCNI will probably not be able to sustain this dividend level.
DP-2.74%
EPS Next 2Y17.25%
EPS Next 3YN/A
DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42
NASDAQ:DHCNI (12/2/2025, 10:31:13 AM)
16.73
+0.03 (+0.18%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners75.89%
Inst Owner ChangeN/A
Ins Owners0.48%
Ins Owner ChangeN/A
Market Cap4.05B
Revenue(TTM)1.54B
Net Income(TTM)-352.11M
Analysts48
Price Target19.63 (17.33%)
Short Float %0.01%
Short Ratio0.55
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.82% |
Yearly Dividend0.04
Dividend Growth(5Y)-45.6%
DP-2.74%
Div Incr Years0
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-142.08%
Min EPS beat(2)-213.15%
Max EPS beat(2)-71.02%
EPS beat(4)1
Avg EPS beat(4)-46.14%
Min EPS beat(4)-213.15%
Max EPS beat(4)122.5%
EPS beat(8)2
Avg EPS beat(8)-24.79%
EPS beat(12)4
Avg EPS beat(12)-9.26%
EPS beat(16)4
Avg EPS beat(16)-20.93%
Revenue beat(2)1
Avg Revenue beat(2)0.09%
Min Revenue beat(2)-0.49%
Max Revenue beat(2)0.67%
Revenue beat(4)2
Avg Revenue beat(4)0.37%
Min Revenue beat(4)-0.49%
Max Revenue beat(4)1.32%
Revenue beat(8)2
Avg Revenue beat(8)-0.49%
Revenue beat(12)5
Avg Revenue beat(12)-0.29%
Revenue beat(16)5
Avg Revenue beat(16)-0.71%
PT rev (1m)15.65%
PT rev (3m)7.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.56%
EPS NY rev (1m)0%
EPS NY rev (3m)-11.49%
Revenue NQ rev (1m)0.47%
Revenue NQ rev (3m)0.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.26%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 2.63 | ||
| P/FCF | N/A | ||
| P/OCF | 216.79 | ||
| P/B | 2.4 | ||
| P/tB | 2.4 | ||
| EV/EBITDA | 27.51 |
EPS(TTM)-1.37
EYN/A
EPS(NY)-0.66
Fwd EYN/A
FCF(TTM)-0.67
FCFYN/A
OCF(TTM)0.08
OCFY0.46%
SpS6.35
BVpS6.97
TBVpS6.97
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.52% | ||
| ROE | -20.85% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 17.58% | ||
| FCFM | N/A |
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
F-Score6
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.61 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 11.41 | ||
| Cap/Depr | 65.29% | ||
| Cap/Sales | 11.78% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 7.83% | ||
| Profit Quality | N/A | ||
| Current Ratio | 6.66 | ||
| Quick Ratio | 6.66 | ||
| Altman-Z | 0.28 |
F-Score6
WACC6.57%
ROIC/WACCN/A
Cap/Depr(3y)103.34%
Cap/Depr(5y)92.72%
Cap/Sales(3y)19.78%
Cap/Sales(5y)17.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3500%
EPS Next Y20.64%
EPS Next 2Y17.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.1%
Revenue growth 3Y2.63%
Revenue growth 5Y7.53%
Sales Q2Q%4.03%
Revenue Next Year3.66%
Revenue Next 2Y3.37%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y46.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year377.31%
EBIT Next 3Y72.02%
EBIT Next 5YN/A
FCF growth 1Y38.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.8%
OCF growth 3YN/A
OCF growth 5Y-15.84%
DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 / DHCNI FAQ
Can you provide the ChartMill fundamental rating for DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42?
ChartMill assigns a fundamental rating of 2 / 10 to DHCNI.
Can you provide the valuation status for DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42?
ChartMill assigns a valuation rating of 0 / 10 to DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI). This can be considered as Overvalued.
How profitable is DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) stock?
DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) has a profitability rating of 1 / 10.
Can you provide the financial health for DHCNI stock?
The financial health rating of DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) is 3 / 10.